In the title compound, the dihedral angle between the 2H-chromen-2-one moiety and the C—CO2 ester grouping is 54.30 (5)°. In the crystal, the molecules are linked by C—H⋯O hydrogen bonds forming C(6) [100] chains.
Keywords: crystal structure, coumarin, Hirshfeld surface analysis
Abstract
In the title compound, C14H14O4, the dihedral angle between the 2H-chromen-2-one moiety and the C—CO2 ester grouping is 54.30 (5)°. In the crystal, the molecules are linked by C—H⋯O hydrogen bonds forming C(6) [100] chains. The contributions to the Hirshfeld surface for the H⋯H, H⋯O/ O⋯H, H⋯C/C⋯H and C⋯C contacts are 49.5, 29.91, 8.6 and 7.7%, respectively.
Structure description
Herein we describe the synthesis, crystal structure and Hirshfeld surface analysis of the title coumarin derivative, C14H14O4. As reported by several authors, coumarin-derived compounds exhibit various biological activities, such as anticancer (Yadav et al., 2024 ▸; Rawat et al., 2022 ▸), anti-inflammatory (Todeschini et al., 1998 ▸) and anti-glaucoma (Ziki et al., 2023 ▸) properties.
As expected, the fused ring system formed by atoms C1–C9/O1/O2 is almost planar with an r.m.s deviation of 0.009 Å and the dihedral angle between this ring system and the plane formed by atoms C11/C11/O3/O4 in the ester grouping is 54.30 (5)° (Fig. 1 ▸).
Figure 1.
The molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
In the crystal, molecules are linked by weak C5—H5⋯O4(x + 1, y, z) hydrogen bonds (Table 1 ▸), thereby generating [100] C(6) chains (Fig. 2 ▸). The Hirshfeld surface and two-dimensional fingerprint plot of the title compound generated by CrystalExplorer21.5 (Spackman et al., 2021 ▸) confirmed the above interaction: the C5—H5⋯O4 bond is indicated by the red spots on Fig. 3 ▸a. The fingerprint plots show that the most important contributions to the surface are H⋯H and H⋯O/O⋯H contacts with 49.5 and 29.1%, respectively (Fig. 3 ▸c and 3e). The H⋯C/C⋯H and C⋯C contacts contribute 8.6 and 7.7%, respectively. These values are close to those of 2-oxo-2H-chromen-7-yl tert-butylacetate (Bazié et al., 2025 ▸).
Table 1. Hydrogen-bond geometry (Å, °).
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| C5—H5⋯O4i | 0.93 | 2.49 | 3.343 (4) | 153 |
Symmetry code: (i)
.
Figure 2.
Part of the extended structure of the title compound showing the formation of [100] hydrogen bonded chains. Symmetry code: (a) x + 1, y, z.
Figure 3.
(a) Hirshfeld surface of the title compound mapped over dnorm, (b) the overall two-dimensional fingerprint plots and (c)–(e) delineated into contributions from different contacts: H⋯H, H⋯C/C⋯H and H⋯O/O⋯H.
Synthesis and crystallization
In a 100 ml round-bottom flask equipped with a condenser, pivaloyl chloride (0.76 ml, 6.17 mmol, 1 equiv.) was dissolved in 16 ml of dried diethyl ether and then dried pyridine (2.31 ml, 4.7 equiv.) and 7-hydroxycoumarin (1 g, 6.17 mmol, 1 equiv.) were added by small portions over 30 min, with vigorous stirring. The reaction mixture was left stirring at room temperature for 3 h.
The resulting mixture was next poured in a separating funnel containing 40 ml of chloroform and washed with 5% hydrochloric acid until the pH was 2–3. The organic phase was extracted, washed with water to neutrality, dried with magnesium sulfate and the solvent removed in vacuo until a cloudy solution was obtained. The occurred precipitate while cooling in an ice bath was filtered off with suction, washed with petroleum ether and recrystallized from a chloroform/n-hexane solvent mixture (1:3) giving the title compound as a white powder (0.96 g, yield 63%). Colourless prisms suitable for single-crystal X-ray diffraction analysis were then formed from an acetone solution, after the solvent was left to evaporate slowly at room temperature, m.p. 403–405 K.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 ▸.
Table 2. Experimental details.
| Crystal data | |
| Chemical formula | C14H14O4 |
| M r | 246.25 |
| Crystal system, space group | Triclinic, P
|
| Temperature (K) | 296 |
| a, b, c (Å) | 6.242 (7), 7.191 (8), 13.652 (16) |
| α, β, γ (°) | 99.05 (6), 92.85 (5), 91.99 (3) |
| V (Å3) | 603.9 (12) |
| Z | 2 |
| Radiation type | Mo Kα |
| μ (mm−1) | 0.10 |
| Crystal size (mm) | 0.41 × 0.12 × 0.04 |
| Data collection | |
| Diffractometer | Bruker D8 Venture |
| No. of measured, independent and observed [I > 2σ(I)] reflections | 43182, 3718, 2693 |
| R int | 0.056 |
| (sin θ/λ)max (Å−1) | 0.719 |
| Refinement | |
| R[F2 > 2σ(F2)], wR(F2), S | 0.052, 0.160, 1.09 |
| No. of reflections | 3718 |
| No. of parameters | 164 |
| H-atom treatment | H-atom parameters constrained |
| Δρmax, Δρmin (e Å−3) | 0.33, −0.27 |
Supplementary Material
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2414314625009496/hb4533sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314625009496/hb4533Isup2.hkl
Supporting information file. DOI: 10.1107/S2414314625009496/hb4533Isup3.cml
CCDC reference: 2498840
Additional supporting information: crystallographic information; 3D view; checkCIF report
Acknowledgments
The authors thank the PMD2X X-ray diffraction facility (https://crm2.univ-lorraine.fr/lab/fr/services/pmd2x) of the Université de Lorraine, for X-ray diffraction measurements and the AFRAMED project. CCDC is also thanked for providing access to the Cambridge Structural Database through the FAIRE program. The authors thank UNESCO, CNRS and the IUCr for their support of the AFRAMED project.
full crystallographic data
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Crystal data
| C14H14O4 | Z = 2 |
| Mr = 246.25 | F(000) = 260 |
| Triclinic, P1 | Dx = 1.354 Mg m−3 |
| Hall symbol: -P 1 | Melting point: 403 K |
| a = 6.242 (7) Å | Mo Kα radiation, λ = 0.71073 Å |
| b = 7.191 (8) Å | Cell parameters from 3418 reflections |
| c = 13.652 (16) Å | θ = 2.9–30.7° |
| α = 99.05 (6)° | µ = 0.10 mm−1 |
| β = 92.85 (5)° | T = 296 K |
| γ = 91.99 (3)° | Prism, colourless |
| V = 603.9 (12) Å3 | 0.41 × 0.12 × 0.04 mm |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Data collection
| Bruker D8 Venture diffractometer | 2693 reflections with I > 2σ(I) |
| Radiation source: fine-focus sealed tube | Rint = 0.056 |
| Mirror monochromator | θmax = 30.7°, θmin = 2.9° |
| φ and ω scans | h = −8→8 |
| 43182 measured reflections | k = −10→10 |
| 3718 independent reflections | l = −19→19 |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Refinement
| Refinement on F2 | Secondary atom site location: difference Fourier map |
| Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
| R[F2 > 2σ(F2)] = 0.052 | H-atom parameters constrained |
| wR(F2) = 0.160 | w = 1/[σ2(Fo2) + (0.0861P)2 + 0.0957P] where P = (Fo2 + 2Fc2)/3 |
| S = 1.09 | (Δ/σ)max < 0.001 |
| 3718 reflections | Δρmax = 0.33 e Å−3 |
| 164 parameters | Δρmin = −0.27 e Å−3 |
| 0 restraints | Extinction correction: SHELXL-2018/3 (Sheldrick 2015b), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
| Primary atom site location: structure-invariant direct methods | Extinction coefficient: 0.033 (8) |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Special details
| Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| O1 | 0.13581 (14) | 0.84613 (12) | 0.39385 (7) | 0.0237 (2) | |
| O4 | 0.06432 (15) | 0.57567 (13) | 0.69115 (7) | 0.0269 (2) | |
| O3 | 0.36060 (14) | 0.76954 (13) | 0.72407 (7) | 0.0254 (2) | |
| O2 | 0.01958 (17) | 0.88911 (16) | 0.24380 (8) | 0.0345 (3) | |
| C8 | 0.2943 (2) | 0.80064 (17) | 0.45874 (9) | 0.0217 (3) | |
| C9 | 0.4981 (2) | 0.75335 (17) | 0.42670 (9) | 0.0223 (3) | |
| C7 | 0.2418 (2) | 0.80648 (17) | 0.55681 (9) | 0.0223 (3) | |
| H7 | 0.106957 | 0.841094 | 0.577328 | 0.027* | |
| C6 | 0.3981 (2) | 0.75876 (17) | 0.62275 (9) | 0.0227 (3) | |
| C4 | 0.6515 (2) | 0.70870 (17) | 0.49681 (10) | 0.0240 (3) | |
| H4 | 0.787880 | 0.677217 | 0.477166 | 0.029* | |
| C10 | 0.1826 (2) | 0.67743 (17) | 0.75051 (9) | 0.0223 (3) | |
| C5 | 0.6034 (2) | 0.71067 (18) | 0.59473 (10) | 0.0242 (3) | |
| H5 | 0.705698 | 0.680589 | 0.640927 | 0.029* | |
| C3 | 0.5370 (2) | 0.75548 (18) | 0.32394 (10) | 0.0252 (3) | |
| H3 | 0.671750 | 0.727749 | 0.300907 | 0.030* | |
| C1 | 0.1690 (2) | 0.84583 (18) | 0.29448 (10) | 0.0260 (3) | |
| C11 | 0.1609 (2) | 0.71001 (18) | 0.86250 (10) | 0.0257 (3) | |
| C2 | 0.3801 (2) | 0.79724 (19) | 0.26079 (10) | 0.0269 (3) | |
| H2 | 0.407245 | 0.794946 | 0.194259 | 0.032* | |
| C13 | −0.0793 (2) | 0.7139 (2) | 0.88096 (11) | 0.0338 (3) | |
| H13A | −0.097988 | 0.734343 | 0.951163 | 0.051* | |
| H13B | −0.141709 | 0.814129 | 0.851933 | 0.051* | |
| H13C | −0.148727 | 0.595837 | 0.851352 | 0.051* | |
| C12 | 0.2761 (2) | 0.8930 (2) | 0.91450 (11) | 0.0325 (3) | |
| H12A | 0.257507 | 0.906684 | 0.984621 | 0.049* | |
| H12B | 0.426308 | 0.889022 | 0.902742 | 0.049* | |
| H12C | 0.216609 | 0.998011 | 0.888773 | 0.049* | |
| C14 | 0.2597 (3) | 0.5410 (2) | 0.90167 (11) | 0.0360 (3) | |
| H14A | 0.249513 | 0.555599 | 0.972376 | 0.054* | |
| H14B | 0.183333 | 0.426808 | 0.870998 | 0.054* | |
| H14C | 0.407801 | 0.535092 | 0.886066 | 0.054* |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| O1 | 0.0223 (4) | 0.0243 (5) | 0.0251 (5) | 0.0022 (3) | 0.0013 (3) | 0.0059 (3) |
| O4 | 0.0259 (5) | 0.0272 (5) | 0.0268 (5) | −0.0036 (4) | 0.0002 (4) | 0.0035 (4) |
| O3 | 0.0244 (5) | 0.0275 (5) | 0.0240 (4) | −0.0028 (4) | 0.0014 (3) | 0.0045 (4) |
| O2 | 0.0309 (5) | 0.0431 (6) | 0.0320 (5) | 0.0033 (4) | −0.0010 (4) | 0.0140 (4) |
| C8 | 0.0221 (6) | 0.0171 (5) | 0.0260 (6) | −0.0005 (4) | 0.0002 (5) | 0.0038 (4) |
| C9 | 0.0226 (6) | 0.0169 (5) | 0.0268 (6) | −0.0018 (4) | 0.0032 (5) | 0.0015 (4) |
| C7 | 0.0212 (6) | 0.0195 (5) | 0.0264 (6) | 0.0006 (4) | 0.0027 (5) | 0.0035 (4) |
| C6 | 0.0249 (6) | 0.0192 (5) | 0.0236 (6) | −0.0023 (4) | 0.0016 (5) | 0.0032 (4) |
| C4 | 0.0209 (6) | 0.0187 (6) | 0.0318 (7) | −0.0006 (4) | 0.0030 (5) | 0.0025 (5) |
| C10 | 0.0211 (6) | 0.0200 (5) | 0.0263 (6) | 0.0016 (4) | 0.0008 (5) | 0.0048 (4) |
| C5 | 0.0224 (6) | 0.0205 (6) | 0.0294 (6) | −0.0008 (4) | −0.0015 (5) | 0.0043 (5) |
| C3 | 0.0241 (6) | 0.0210 (6) | 0.0303 (6) | −0.0008 (5) | 0.0056 (5) | 0.0025 (5) |
| C1 | 0.0285 (7) | 0.0231 (6) | 0.0268 (6) | −0.0008 (5) | 0.0015 (5) | 0.0062 (5) |
| C11 | 0.0278 (6) | 0.0261 (6) | 0.0232 (6) | 0.0011 (5) | 0.0009 (5) | 0.0042 (5) |
| C2 | 0.0302 (7) | 0.0250 (6) | 0.0256 (6) | −0.0019 (5) | 0.0053 (5) | 0.0040 (5) |
| C13 | 0.0315 (7) | 0.0394 (8) | 0.0305 (7) | −0.0006 (6) | 0.0085 (6) | 0.0035 (6) |
| C12 | 0.0377 (8) | 0.0313 (7) | 0.0269 (7) | −0.0007 (6) | −0.0001 (6) | 0.0011 (5) |
| C14 | 0.0481 (9) | 0.0333 (8) | 0.0282 (7) | 0.0070 (6) | 0.0009 (6) | 0.0085 (6) |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Geometric parameters (Å, º)
| O1—C8 | 1.3772 (19) | C3—C2 | 1.346 (2) |
| O1—C1 | 1.382 (2) | C3—H3 | 0.9300 |
| O4—C10 | 1.2058 (19) | C1—C2 | 1.453 (2) |
| O3—C10 | 1.3668 (19) | C11—C12 | 1.530 (2) |
| O3—C6 | 1.405 (2) | C11—C13 | 1.534 (3) |
| O2—C1 | 1.212 (2) | C11—C14 | 1.539 (2) |
| C8—C7 | 1.389 (2) | C2—H2 | 0.9300 |
| C8—C9 | 1.402 (2) | C13—H13A | 0.9600 |
| C9—C4 | 1.401 (2) | C13—H13B | 0.9600 |
| C9—C3 | 1.438 (2) | C13—H13C | 0.9600 |
| C7—C6 | 1.383 (2) | C12—H12A | 0.9600 |
| C7—H7 | 0.9300 | C12—H12B | 0.9600 |
| C6—C5 | 1.395 (2) | C12—H12C | 0.9600 |
| C4—C5 | 1.383 (2) | C14—H14A | 0.9600 |
| C4—H4 | 0.9300 | C14—H14B | 0.9600 |
| C10—C11 | 1.523 (3) | C14—H14C | 0.9600 |
| C5—H5 | 0.9300 | ||
| C8—O1—C1 | 121.89 (12) | O1—C1—C2 | 117.24 (12) |
| C10—O3—C6 | 118.83 (11) | C10—C11—C12 | 112.83 (13) |
| O1—C8—C7 | 116.55 (13) | C10—C11—C13 | 107.60 (12) |
| O1—C8—C9 | 121.17 (13) | C12—C11—C13 | 110.08 (13) |
| C7—C8—C9 | 122.28 (12) | C10—C11—C14 | 106.56 (12) |
| C4—C9—C8 | 118.06 (14) | C12—C11—C14 | 109.61 (14) |
| C4—C9—C3 | 124.18 (13) | C13—C11—C14 | 110.08 (13) |
| C8—C9—C3 | 117.76 (12) | C3—C2—C1 | 121.31 (14) |
| C6—C7—C8 | 117.34 (13) | C3—C2—H2 | 119.3 |
| C6—C7—H7 | 121.3 | C1—C2—H2 | 119.3 |
| C8—C7—H7 | 121.3 | C11—C13—H13A | 109.5 |
| C7—C6—C5 | 122.65 (14) | C11—C13—H13B | 109.5 |
| C7—C6—O3 | 120.70 (13) | H13A—C13—H13B | 109.5 |
| C5—C6—O3 | 116.50 (12) | C11—C13—H13C | 109.5 |
| C5—C4—C9 | 121.07 (14) | H13A—C13—H13C | 109.5 |
| C5—C4—H4 | 119.5 | H13B—C13—H13C | 109.5 |
| C9—C4—H4 | 119.5 | C11—C12—H12A | 109.5 |
| O4—C10—O3 | 122.82 (13) | C11—C12—H12B | 109.5 |
| O4—C10—C11 | 124.93 (13) | H12A—C12—H12B | 109.5 |
| O3—C10—C11 | 112.17 (12) | C11—C12—H12C | 109.5 |
| C4—C5—C6 | 118.57 (12) | H12A—C12—H12C | 109.5 |
| C4—C5—H5 | 120.7 | H12B—C12—H12C | 109.5 |
| C6—C5—H5 | 120.7 | C11—C14—H14A | 109.5 |
| C2—C3—C9 | 120.62 (14) | C11—C14—H14B | 109.5 |
| C2—C3—H3 | 119.7 | H14A—C14—H14B | 109.5 |
| C9—C3—H3 | 119.7 | C11—C14—H14C | 109.5 |
| O2—C1—O1 | 116.69 (14) | H14A—C14—H14C | 109.5 |
| O2—C1—C2 | 126.05 (15) | H14B—C14—H14C | 109.5 |
2-Oxo-2H-chromen-7-yl 2,2-dimethylpropionate . Hydrogen-bond geometry (Å, º)
| D—H···A | D—H | H···A | D···A | D—H···A |
| C5—H5···O4i | 0.93 | 2.49 | 3.343 (4) | 153 |
Symmetry code: (i) x+1, y, z.
References
- Bazié, H., Ziki, E., Brahima, S., Ratsimbazafy, V., Roge, P., Wenger, E., Djandé, A. & Lecomte, C. (2025). IUCrData10, x250189. [DOI] [PMC free article] [PubMed]
- Bruker (2019). APEX4 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
- Rawat, A. A. & Reddy, V. B. (2022). Eur J. Med. Chem. Rep.5, 100038.
- Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
- Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
- Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst.54, 1006–1011. [DOI] [PMC free article] [PubMed]
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
- Todeschini, A. R., de Miranda, A. L. P., da Silva, K. C. M., Parrini, S. C. & Barreiro, E. J. (1998). Eur. J. Med. Chem.33, 189–199.
- Westrip, S. P. (2010). J. Appl. Cryst.43, 920–925.
- Yadav, A. K., Maharjan Shrestha, R. & Yadav, P. N. (2024). Eur. J. Med. Chem.267, 116179. [DOI] [PubMed]
- Ziki, E., Akonan, L., Kouman, K. C., Dali, D., Megnassan, E., Kakou-Yao, R., Tenon, A. J., Frecer, V. & Miertus, S. J. (2023). J. Pharm. Res. Int.35, 10–33.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2414314625009496/hb4533sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314625009496/hb4533Isup2.hkl
Supporting information file. DOI: 10.1107/S2414314625009496/hb4533Isup3.cml
CCDC reference: 2498840
Additional supporting information: crystallographic information; 3D view; checkCIF report




